The Ordinary General Meeting of Shareholders 2020 of Vivoryon Therapeutics AG took place on September 30, 2020, at 11:00 am (CEST) at the registered office of Vivoryon Therapeutics AG, Weinbergweg 22, 06120 Halle (Saale), Germany.

• Notice of Ordinary General Meeting of Shareholders including Agenda, notes pursuant to Sec. 124a No. 2 and 4 AktG and management board report regarding certain agenda items
  • Conversion Report pursuant to sec. 192 para. 1 German Transformation Act (UmwG)

 

• Annual Financial Statements of Vivoryon Therapeutics AG for the financial year 2019 prepared in accordance with the German GAAP (“HGB”) as well as the Management Report of Vivoryon Therapeutics AG including an Explanatory Report of the Management Board on the statements pursuant to § 289 (4) of the Commercial Code (HGB)
• Annual Financial Statements of Vivoryon Therapeutics AG for the financial year 2019 prepared in accordance with IFRS as endorsed by the European Union
• Annual Report 2019
• Report of the Supervisory Board for the financial year 2019

 

• Information on attendance at the Ordinary General Meeting of Shareholders and representation of voting rights
• Information on Shareholders’ Rights
• Forms to be used if the voting right is exercised by proxy
  • Form Voting Proxy
  • Form Authorisation and Instructions to the Proxies
• Shareholders’ Counterproposals and Election Nominations

 

• Articles of Association
• Draft Articles of association under Dutch law

 

• Map/Directions
• Voting results
• Privacy Notice for Shareholders of Vivoryon Therapeutics